TZ Limited Raises AU$750 Thousand to Support Microsoft-Driven Growth and Strengthen Operations.
TZ Limited (ASX: TZL) has successfully completed a strongly supported AU$750,000 placement at AU$0.05 per share, surpassing its original AU$500,000 target. The funding—secured from major shareholders—will support accelerated delivery for recent Data Centre Security contract wins, including deployments for Microsoft facilities. Despite global tariff disruptions, revenue in this division grew from AU$1.6 million in FY24 to AU$2.1 million in FY25, with more than AU$3 million already secured for FY26 and further upside potential through active tenders.
The company is also prioritizing balance sheet improvement, with an upcoming AU$2.75 million debt repayment set to reduce total group debt from approximately AU$6.25 million to AU$3.5 million. Concurrently, TZ is advancing the strategic review of its US subsidiary, Telezygology Inc., which currently generates AU$2.7 million in ARR and could lift its run-rate to more than AU$4.7 million through ongoing commercial engagements. TZ continues to scale across smart locking, data centre security, and smart building technology platforms.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
TZ Limited Raises AU$750 Thousand to Support Microsoft-Driven Growth and Strengthen Operations.
TZ Limited (ASX: TZL) has successfully completed a strongly supported AU$750,000 placement at AU$0.05 per share, surpassing its original AU$500,000 target. The funding—secured from major shareholders—will support accelerated delivery for recent Data Centre Security contract wins, including deployments for Microsoft facilities. Despite global tariff disruptions, revenue in this division grew from AU$1.6 million in FY24 to AU$2.1 million in FY25, with more than AU$3 million already secured for FY26 and further upside potential through active tenders.
The company is also prioritizing balance sheet improvement, with an upcoming AU$2.75 million debt repayment set to reduce total group debt from approximately AU$6.25 million to AU$3.5 million. Concurrently, TZ is advancing the strategic review of its US subsidiary, Telezygology Inc., which currently generates AU$2.7 million in ARR and could lift its run-rate to more than AU$4.7 million through ongoing commercial engagements. TZ continues to scale across smart locking, data centre security, and smart building technology platforms.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au